Tolmetin Sodium NDC 72336-118

NDC codes

FDA NDC Directory

Product NDC (as listed)72336-118Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72336-0118Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72336-118-30	72336011830	30 TABLET in 1 BOTTLE (72336-118-30)Marketed from May 5, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tolmetin Sodium
Generic name (nonproprietary): tolmetin sodium
Active ingredients: Tolmetin sodium — 200 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Lifsa Drugs LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 073588
Marketing start: Jul 31, 1992
Listing expires: Dec 31, 2027
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 72336-118_513fcbbb-b0a8-55e9-e063-6394a90a5e05SPL ID 513fcbbb-b0a8-55e9-e063-6394a90a5e05SPL set ID 7b26321c-4797-4664-a162-e29de4b8dd93RxCUI 198295UNII 02N1TZF99FUPC 0372336118309
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472336011830 followed by a unit qualifier and the quantity

Package 72336-0118-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 7, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Carefully consider the potential benefits and risks of tolmetin sodium tablets and other treatment options before deciding to use tolmetin sodium tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Tolmetin sodium tablets are indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis. Tolmetin sodium tablets are indicated in the treatment of acute flares and the long-term management of the chronic disease. Tolmetin sodium tablets are also indicated for treatment of juvenile rheumatoid arthritis. The safety and effectiveness of tolmetin have not been establishe…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 073588

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 073588
Product	Strength	Form · route	Labeler	Product NDC
Tolmetin Sodium	Tolmetin sodium 200 mg/1	TabletOral	Chartwell RX, LLC	62135-062